P.H. Degen

1.2k total citations
46 papers, 1.0k citations indexed

About

P.H. Degen is a scholar working on Spectroscopy, Analytical Chemistry and Pharmacology. According to data from OpenAlex, P.H. Degen has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Spectroscopy, 12 papers in Analytical Chemistry and 10 papers in Pharmacology. Recurrent topics in P.H. Degen's work include Analytical Chemistry and Chromatography (18 papers), Analytical Methods in Pharmaceuticals (11 papers) and Inflammatory mediators and NSAID effects (6 papers). P.H. Degen is often cited by papers focused on Analytical Chemistry and Chromatography (18 papers), Analytical Methods in Pharmaceuticals (11 papers) and Inflammatory mediators and NSAID effects (6 papers). P.H. Degen collaborates with scholars based in Switzerland, United Kingdom and Malaysia. P.H. Degen's co-authors include W. Rieß, Werner Schneider, Gérard Flesch, A. Schweizer, A. Sioufi, Uzi Geiger, W Theobald, Karl Schmid, J. Moppert and W. Dieterle and has published in prestigious journals such as Analytical Biochemistry, Journal of Chromatography A and Journal of Pharmaceutical Sciences.

In The Last Decade

P.H. Degen

45 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.H. Degen Switzerland	20	321	283	262	179	143	46	1.0k
B. Norlander Sweden	23	281 0.9×	214 0.8×	195 0.7×	153 0.9×	144 1.0×	53	1.1k
Gilles Caillé Canada	20	357 1.1×	275 1.0×	162 0.6×	210 1.2×	128 0.9×	73	1.1k
M.T. Rosseel Belgium	22	376 1.2×	312 1.1×	248 0.9×	167 0.9×	105 0.7×	69	1.3k
G.J. Krol United States	18	398 1.2×	148 0.5×	163 0.6×	135 0.8×	151 1.1×	37	1.1k
Helle R. Angelo Denmark	19	230 0.7×	139 0.5×	176 0.7×	288 1.6×	79 0.6×	79	1.4k
K. O. Borg Sweden	16	175 0.5×	226 0.8×	144 0.5×	276 1.5×	122 0.9×	28	999
J.K. Cooper Canada	17	196 0.6×	180 0.6×	228 0.9×	179 1.0×	69 0.5×	61	778
Samuel F. Sisenwine United States	18	240 0.7×	115 0.4×	203 0.8×	298 1.7×	110 0.8×	56	1.1k
Richard A. Okerholm United States	18	170 0.5×	129 0.5×	110 0.4×	193 1.1×	119 0.8×	36	842
J. Girault France	19	147 0.5×	175 0.6×	179 0.7×	115 0.6×	91 0.6×	47	1.2k

Countries citing papers authored by P.H. Degen

Since Specialization

Citations

This map shows the geographic impact of P.H. Degen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.H. Degen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.H. Degen more than expected).

Fields of papers citing papers by P.H. Degen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.H. Degen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.H. Degen. The network helps show where P.H. Degen may publish in the future.

Co-authorship network of co-authors of P.H. Degen

This figure shows the co-authorship network connecting the top 25 collaborators of P.H. Degen. A scholar is included among the top collaborators of P.H. Degen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.H. Degen. P.H. Degen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lefèvre, Gilbert, et al.. (2002). Comparison of the cardiac effects of the antimalarials co-artemether and halofantrine in healthy participants.. American Journal of Tropical Medicine and Hygiene. 66(3). 293–298. 28 indexed citations

Flesch, Gérard, et al.. (1997). Quantitative determination of CGP 61755, a protease inhibitor, in plasma and urine by high-performance liquid chromatography and fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 696(1). 123–130. 4 indexed citations

Degen, P.H., et al.. (1997). An enzyme inhibition assay for the quantitative determination of the new bisphosphonate zoledronate in plasma. Journal of Pharmaceutical and Biomedical Analysis. 15(12). 1877–1880. 15 indexed citations

Degen, P.H., et al.. (1997). Pharmacokinetic and pharmacodynamic interaction of single oral doses of valsartan and furosemide. European Journal of Clinical Pharmacology. 52(5). 371–378. 24 indexed citations

Degen, P.H., et al.. (1996). Automated quantitative determination of a new polyamine biosynthesis inhibitor (CGP 48 664) and a potential metabolite in human and animal plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 681(2). 339–345. 6 indexed citations

Navaratnam, V., et al.. (1996). Determination of a new antimalarial drug, benflumetol, in blood plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 682(2). 321–325. 40 indexed citations

Cardot, J, et al.. (1995). Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady state. Biopharmaceutics & Drug Disposition. 16(7). 603–614. 21 indexed citations

Degen, P.H., et al.. (1994). The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers. Biopharmaceutics & Drug Disposition. 15(6). 519–526. 23 indexed citations

Flesch, Gérard, et al.. (1994). Quantitative determination of CGP 53 437, a new HIV protease inhibitor, in plasma by high-performance liquid chromatography and fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 657(1). 155–161. 2 indexed citations

10.

Chan, Keith K. H., et al.. (1993). Urinary Excretion of Aminohydroxypropylidene Bisphosphonate in Cancer Patients after Single Intravenous Infusions. Journal of Pharmaceutical Sciences. 82(6). 665–667. 8 indexed citations

11.

Degen, P.H., et al.. (1993). Influence of food on the disposition of the monoamine oxidase‐A inhibitor brofaromine in healthy volunteers. Biopharmaceutics & Drug Disposition. 14(3). 209–215. 1 indexed citations

12.

Flesch, Gérard, et al.. (1992). Determination of the R-(−) and S-(+) enantiomers of the monohydroxylated metabolite of oxcarbazepine in human plasma by enantioselective high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 581(1). 147–151. 40 indexed citations

13.

Degen, P.H., et al.. (1992). Improved determination of brofaromine by capillary gas chromatography and by utilization of a multi-purpose injector. Journal of Chromatography A. 623(1). 191–195. 1 indexed citations

14.

Gräf, Peter, et al.. (1992). Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril. Journal of Hypertension. 10(9). 1045???1052–1045???1052. 9 indexed citations

15.

Degen, P.H. & Werner Schneider. (1991). Rapid and sensitive determination of low concentrations of nicotine in plasma by gas chromatography with nitrogen-specific detection. Journal of Chromatography B Biomedical Sciences and Applications. 563(1). 193–198. 10 indexed citations

16.

Weißenborn, Karin, et al.. (1991). Burst suppression EEG with baclofen overdose. Clinical Neurology and Neurosurgery. 93(1). 77–80. 38 indexed citations

17.

Schneider, Werner, B T Keller, & P.H. Degen. (1989). Determination of the new monoamine oxidase inhibitor brofaromine and its major metabolite in biological material by gas chromatography with electron-capture detection. Journal of Chromatography B Biomedical Sciences and Applications. 488(1). 275–282. 11 indexed citations

18.

Degen, P.H., et al.. (1988). Pharmacokinetics of Diclofenac and Five Metabolites After Single Doses in Healthy Volunteers and After Repeated Doses in Patients. Xenobiotica. 18(12). 1449–1455. 29 indexed citations

19.

Degen, P.H., et al.. (1976). The determination of phanquone in biological material by gas-liquid chromatography. Journal of Chromatography A. 118(3). 363–370. 6 indexed citations

20.

Geiger, Uzi, P.H. Degen, & A. Sioufi. (1975). Quantitative assay of diclofenac in biological material by gas—liquid chromatography. Journal of Chromatography A. 111(2). 293–295. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact